Marcin Kowalski, MD
Clinical Cardiac Electrophysiology · Staten Island, NYNPI 1881896199
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (33.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Medtronic at 46.9% of the total. Reporting peaked in 2019 at $33,122 and has fallen 68.8% since, to $10,320 in 2025.
Across 331 payments — averaging $358.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$56K
- Philips North America LLC$18K
- Abbott$18K
- Adagio Medical, Inc.$12K
- Biosense Webster, Inc.$11K
- Cvrx, Inc.$1K
- plus $3K from 12 others
Across 116 payments — averaging $1812.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$152K
- Atricure, Inc.$43K
- Adagio Medical, Inc.$16K
What the payments were for
- Consulting fees$29,06324%
- Speaking & faculty fees$40,08834%
- Travel & lodging$35,80230%
- Food & beverage$13,79012%
- Education$410%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 113 | $55,750 |
| Philips North America LLC | 7 | $18,109 |
| Abbott | 119 | $17,885 |
| Adagio Medical, Inc. | 9 | $11,968 |
| Biosense Webster, Inc. | 24 | $11,101 |
| Cvrx, Inc. | 15 | $1,222 |
| Boston Scientific | 16 | $1,030 |
| Zywie, Inc. | 1 | $550 |
| Kestra Medical Technology Services, Inc. | 8 | $469 |
| Atricure, Inc. | 3 | $206 |
| Cardiofocus, Inc. | 2 | $200 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $78 |
| Pfizer | 1 | $58 |
| Biotronik Inc. | 4 | $57 |
| Cardiva Medical, Inc. | 2 | $45 |
| Irhythm Technologies, Inc. | 1 | $20 |
| Novartis | 1 | $20 |
| Bardy Diagnostics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Arctic Front$36,325
- AVEIR$11,543
- Spectranetics Undiv$8,543
- (9520) IGT Devices Undivided$8,000
- Carto 3$6,884
- IGT D Peripheral$1,500
- LINQ II$1,174
- CARDIOBLATE CRYOFLEX$1,043
- Accent Pacemaker$1,000
- Barostim Neo System$939
- GALLANT$650
- ARCTIC FRONT ADVANCE$633
- COREVALVE EVOLUT R$531
- TENDRIL$525
- DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER$402
- Micra$241
- Assure WCD$234
- GENERAL - THERAPIES$164
- ASSURITY$162
- AMPLATZER$147
How this compares
$118,784 in reported general payments places this provider in the 85th percentile of 214 clinical cardiac electrophysiology providers in New York.
See all clinical cardiac electrophysiology providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 60 | $86,984 |
| PradaxaDabigatran Etexilate Mesylate | 13 | $3,501 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 20 | $2,059 |
| Metoprolol Succinate | 87 | $1,712 |
| ClopidogrelClopidogrel Bisulfate | 11 | $164 |
| SotalolSotalol Hcl | 11 | $134 |
| Metoprolol Tartrate | 20 | $94 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $58 | $86,98460 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 214 clinical cardiac electrophysiology providers in New York.
Other clinical cardiac electrophysiology in Staten Island
- Valay ParikhStaten Island$49K
- Vivek ReddyNew York$14.9M
- Jacob KoruthNew York$3.7M
- Srinivas DukkipatiNew York$2.7M
- Amir AhmadiNew York$789K
- Larry ChinitzNew York$448K
- Felix YangBrooklyn$407K
- James IpNew York$347K
- Stavros MountantonakisManhasset$321K
- Jorge RomeroSyracuse$295K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.